Institut de Cancérologie de Lorraine
Vandœuvre-lès-Nancy, 54500, France
NCT Number: NCT02865239
Breast MRI is performed in prone position which causes a number of questions. Indeed, the correlation with mammography and echography and the identification of preoperative lesions can be complex as echography and surgery are carried in supine position while mammography is performed in standing position.
Moreover, the prone position is often considered as uncomfortable by the patients. However, there is few publications in the literature on breast MRI in decubitus position.
Looking for future studies?
Notify MeUp to 18 year
Female
Interventional
Not applicable
Vandœuvre-lès-Nancy, 54500, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Eligible patients will have a standard MRI in prone position. At the end of this examination, all patients will have an other standard MRI in supine position.
This examination is then extended by 10 minutes without additional injection of contrast medium
Time frame: 1 day
The topography is considered discordant if the location of the lesion is different between prone and supine positions (location will be described as the positions on a clock) and / or the distance from the nipple to the lesion is greater than 2cm between prone and supine positions.
Time frame: 1 day
Time frame: 1 day
Time frame: 1 day
Time frame: 1 day
Time frame: 1 day
Institut de Cancérologie de Lorraine
Other
Acronym: EFIMED
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05708144
Breast Cancer, Breast Diseases
Xiamen, Fujian, China
View Trial DetailsNCT00128856
Breast Cancer, Breast Diseases
Badalona, Barcelona, Spain
View Trial DetailsNCT00086762
Breast Cancer, Breast Diseases
Wichita, Kansas, United States
View Trial DetailsNCT01373671
Breast Cancer, Breast Diseases
Malvern, Pennsylvania, United States
View Trial Details